Navigation Links
BiotechWatch Launches The Biotech Forum
Date:10/18/2007

A platform for biotechnology investors and professionals to share

resources, ideas and perspectives on the biotechnology sector

FARMINGTON HILLS, Mich., Oct. 18 /PRNewswire/ -- BiotechWatch, LLC the leading source of unbiased, comprehensive and timely information on the biotechnology sector has expanded its offerings to the biotech investor and biotechnology professional with the launch of The Biotech Forums. Within The Biotech Forums, groups discuss upcoming PDUFA decisions, FDA decisions, Phase 3 clinical results, biotech trends, new up and coming biotech companies, cutting edge research and compelling biotechnology stock investments. Access to The Biotech Forums is free to all our members (http://www.biotechwatch.com).

The Biotech Forums complement BiotechWatch's database offerings, which include the BiotechWatch Premium Database that offers in-depth coverage of biotechnology companies in the sector, giving the user the ability to search and sort based on more than twenty parameters. Perform, save, and print customized sector-wide searches on parameters such as cash on hand, burn rate, clinical trial status, pending milestones and medical indication. The Premium Database provides the user the unparalleled ability to integrate both financial and clinical data. Our TrialView Database offers disease-specific and biotechnology sector-wide clinical trial information. The TrialView Database allows the user to point and click on any of 200 diseases or 20 medical specialties to identify biotech products under development and their associated biotech companies. Finally, the average investor has access to the same powerful investment search tools that were once limited to investment professionals.

About BiotechWatch, LLC:

BiotechWatch, LLC is the leading source of unbiased, comprehensive, and timely information on the biotech sector. Only BiotechWatch maintains proprietary databases of over 500 publicly traded biotechnology companies that integrate both clinical trial information and company financials. The combination of constant updates and real-time Internet delivery ensure that the results generated from these databases and our other products are accurate and up-to-the minute to better serve the needs of the biotech investor and professional.


'/>"/>
SOURCE BiotechWatch, LLC
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Merge launches diagnostic mammography workstation in Europe
2. Einstein Wireless launches cellular alert system
3. Logistics Health launches compliance management tool
4. UW-Madison launches new high-speed research network
5. UWM launches research foundation
6. TeraMedica launches information manager
7. GE Healthcare launches hybrid electronic record
8. Cedara launches new version of DICOM toolkit
9. Merge launches Spanish version of imaging tool
10. Doyle launches 2025 alternative energy plan
11. Jellyfish launches comparative shopping website
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... 27, 2016 /PRNewswire/ - BIOREM Inc. (TSX-V: BRM) ("Biorem" or ... its major shareholders, Clean Technology Fund I, LP and ... based venture capital funds which together hold ... a fully diluted, as converted basis), that they have ... entire equity holdings in Biorem to TUS Holdings Co. ...
(Date:6/27/2016)... ... 2016 , ... Parallel 6 , the leading software as a service ... Virtual Patient Encounter CONSULT module which enables both audio and video telemedicine communication ... , Using the CONSULT module, patients and physicians can schedule a face to face ...
(Date:6/27/2016)...  Liquid Biotech USA , ... Sponsored Research Agreement with The University of Pennsylvania ... cancer patients.  The funding will be used to ... clinical outcomes in cancer patients undergoing a variety ... employed to support the design of a therapeutic, ...
(Date:6/24/2016)... 24, 2016 Epic Sciences unveiled a ... susceptible to PARP inhibitors by targeting homologous recombination ... The new test has already been incorporated into ... cancer types. Over 230 clinical trials ... pathways, including PARP, ATM, ATR, DNA-PK and WEE-1. ...
Breaking Biology Technology:
(Date:5/12/2016)... , May 12, 2016 WearablesResearch.com ... just published the overview results from the Q1 wave ... the recent wave was consumers, receptivity to a program ... data with a health insurance company. "We ... to share," says Michael LaColla , CEO of ...
(Date:5/3/2016)... 3, 2016  Neurotechnology, a provider of high-precision ... Automated Biometric Identification System (ABIS) , a complete ... MegaMatcher ABIS can process multiple complex biometric transactions ... of fingerprint, face or iris biometrics. It leverages ... and MegaMatcher Accelerator , which have been ...
(Date:4/28/2016)... -- First quarter 2016:   , Revenues ... first quarter of 2015 The gross margin was 49% ... and the operating margin was 40% (-13) Earnings per ... from operations was SEK 249.9 M (21.2) , Outlook ... 7,000-8,500 M. The operating margin for 2016 is estimated ...
Breaking Biology News(10 mins):